Progress in the treatment of primary gastric diffuse large B-cell lymphoma
The stomach is the most common site of primary gastrointestinal lymphoma(PGIL),with diffuse large B-cell lymphoma(DLBCL)being the main type of non-Hodgkin's lymphoma.It has high heterogeneity in clinical manifestations,immunophenotype,and molecular genetics,and is difficult to differentiate from other benign and malignant tumours.The incidence of primary gastric DLBCL has shown the significant upward trend in recent years.Although therapeutic approaches for this disease have been continuously innovated and improved in the past decade,there is still no uniform treatment model.This article elaborates on the standardized treatment schemes and the latest treatment research of gastric DLBCL,in order to bring better treatment schemes for patients.
万方数据
维普
